Healthcare, Biotech & Pharma - RNA Technologies

Ribonucleic acid or RNA-based therapies are emerging as new drug classes. The global market for RNA-based therapies was valued at $5.2 billion in 2023 and is expected to reach $17.2 billion by 2027 with a growth rate of 35 percent.

The report then analyzes RNA vaccine technology and technology on RNA stabilization and release. At the end, the paper presents an analysis on complementary diagnostics and precision medicine, where RNA is becoming a key factor for dysgnostics.

DOWNLOAD THE ABSTRACT OF THE REPORT FOR FREE. IF YOU ARE INTERESTED IN THE FULL VERSION OF THE REPORT WRITE TO businessdevelopment@intesasanpaoloinnovationcenter.com.